Budesonide/form 80/4.5mcg (120 Inh)

Manufacturer PRASCO LABORATORIES Active Ingredient Budesonide and Formoterol Inhalation Aerosol(byoo DES oh nide & for MOH te rol) Pronunciation byoo-DES-oh-nide & for-MOH-te-rol
It is used to treat COPD (chronic obstructive pulmonary disease).It is used to treat asthma.Do not use this drug to treat intense flare- ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
đŸˇī¸
Drug Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Agonist (LABA) Combination
đŸ§Ŧ
Pharmacologic Class
Glucocorticoid; Beta2-adrenergic Agonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jul 2006
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is an inhaler that contains two medicines: a corticosteroid (budesonide) and a long-acting bronchodilator (formoterol). The corticosteroid helps reduce inflammation in your lungs, making it easier to breathe. The bronchodilator helps open up your airways for up to 12 hours. It's used regularly, usually twice a day, to prevent asthma attacks or manage COPD symptoms. It is NOT for sudden breathing problems.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only. Continue using it as directed by your doctor or healthcare provider, even if you feel well.

Preparing and Using the Inhaler

Before using the inhaler for the first time, or if it has not been used for more than 7 days, or if it has been dropped, prepare it by spraying 2 test sprays into the air. Shake the inhaler well for 5 seconds before each test spray. Before each use, shake the inhaler well for 5 seconds. After each use, rinse your mouth with water, but do not swallow the water. Spit it out. Replace the cap on the inhaler after each use.

Tracking Your Doses

The inhaler has a dose counter to help you keep track of the number of doses left. Dispose of the inhaler when you have been instructed to do so after opening, or when the dose counter reaches "0", whichever comes first.

Important Handling and Storage Instructions

Never wash the inhaler, and keep it dry. If you are using more than one inhaled medication, ask your doctor which one to use first. If you accidentally get the medication in your eyes, rinse them immediately with water. If you experience eye irritation that lasts or a change in vision, contact your doctor.

Storage and Disposal

Store the medication at room temperature. Discard any unused portion 3 months after removing it from the foil package. Protect the medication from heat or open flames. Do not puncture or burn the inhaler, even if it seems empty.

Missing a Dose

If you miss a dose, skip it and return to your regular dosing schedule. Do not use two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Use exactly as prescribed, usually two puffs twice a day, every day, even if you feel well.
  • Do NOT use for sudden shortness of breath; use your fast-acting rescue inhaler for that.
  • Rinse your mouth with water and spit it out after each dose to help prevent oral thrush (a fungal infection in the mouth).
  • Do not exceed the prescribed dose.
  • Keep track of the number of inhalations used and discard the inhaler after the labeled number of puffs or expiration date.
  • Shake the inhaler well before each use.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 2 inhalations (80/4.5 mcg each) twice daily, approximately 12 hours apart
Dose Range: 80 - 160 mg

Condition-Specific Dosing:

asthma: Initial dose: 2 inhalations (80/4.5 mcg) twice daily. Max dose: 2 inhalations (160/4.5 mcg) twice daily.
copd: 2 inhalations (160/4.5 mcg) twice daily (Note: 80/4.5 mcg strength is not indicated for COPD).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: 6 to <12 years: 2 inhalations (80/4.5 mcg) twice daily.
Adolescent: â‰Ĩ12 years: 2 inhalations (80/4.5 mcg) twice daily (for asthma). Max dose: 2 inhalations (160/4.5 mcg) twice daily.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended.
Moderate: No specific dose adjustment recommended.
Severe: No specific dose adjustment recommended.
Dialysis: No specific considerations; systemic exposure is low.

Hepatic Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Consider dose reduction for budesonide due to increased systemic exposure. Monitor for signs of corticosteroid effects.
Severe: Use with caution. Significant increase in systemic exposure to budesonide is possible. Monitor closely for corticosteroid effects.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Budesonide is a potent glucocorticoid with anti-inflammatory properties. It reduces inflammation in the airways, decreasing hyperresponsiveness. Formoterol is a long-acting selective beta2-adrenergic agonist (LABA) that stimulates beta2-receptors in the bronchial smooth muscle, leading to bronchodilation and relaxation of the airways.
📊

Pharmacokinetics

Absorption:

Bioavailability: Budesonide: ~39% (oral inhalation); Formoterol: ~43% (oral inhalation)
Tmax: Budesonide: 10-30 minutes; Formoterol: 10 minutes
FoodEffect: Not applicable for inhaled administration.

Distribution:

Vd: Budesonide: ~3 L/kg; Formoterol: ~4 L/kg
ProteinBinding: Budesonide: ~85-90%; Formoterol: ~50%
CnssPenetration: Limited

Elimination:

HalfLife: Budesonide: ~2-4 hours; Formoterol: ~8-10 hours
Clearance: Budesonide: ~1.4 L/min; Formoterol: ~150 mL/min
ExcretionRoute: Budesonide: Urine (60%) and feces (40%); Formoterol: Urine (60%) and feces (30%)
Unchanged: Budesonide: <1% (urine); Formoterol: ~7-10% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Formoterol: Within 1-3 minutes
PeakEffect: Formoterol: Within 10-30 minutes; Budesonide: Days to weeks for full anti-inflammatory effect
DurationOfAction: Formoterol: Up to 12 hours; Budesonide: Sustained anti-inflammatory effect with twice-daily dosing

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as formoterol, increase the risk of asthma-related death. Data from a large, placebo-controlled US study showed an increase in asthma-related deaths in patients receiving salmeterol (another LABA) compared to placebo. This finding is considered a class effect of LABAs, including formoterol. Therefore, Budesonide/Formoterol is not indicated for the relief of acute bronchospasm and should only be used in patients with asthma who are currently receiving a long-term asthma control medication, such as an inhaled corticosteroid, but whose asthma is not adequately controlled on that medication, or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a LABA.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of high blood sugar, such as:
+ Confusion
+ Drowsiness
+ Excessive thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ Abnormal heartbeat
Signs of a weak adrenal gland, such as:
+ Severe nausea or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Fatigue
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Fainting
+ Changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Nervousness or excitability
Bone pain
Dizziness or fainting
Seizures
Severe nausea or vomiting
Fatigue or weakness
Sleep disturbances
Abnormal sensations, such as burning, numbness, or tingling
Flu-like symptoms
Sinus pain
Changes in vision, eye pain, or severe eye irritation
Redness or white patches in the mouth or throat
Mouth irritation or mouth sores

Respiratory Problems: A Life-Threatening Condition

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical attention if you notice any of the following:

Headache
Stomach pain
Nose or throat irritation
Common cold symptoms
Back pain
Nausea or vomiting

These are not all the possible side effects that may occur. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening breathing problems (e.g., increased wheezing, shortness of breath, cough)
  • Increased need for your rescue inhaler
  • Chest pain or fast/pounding heartbeat
  • Severe headache
  • Tremor or nervousness
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Blurred vision or eye pain
  • New or worsening muscle cramps or weakness
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking another medication similar to this one. If you are unsure, consult your doctor or pharmacist for clarification.

Please note that this is not an exhaustive list of all potential interactions with this medication. To ensure your safety, it is crucial to discuss the following with your doctor and pharmacist:

All prescription and over-the-counter medications you are taking
Any natural products or vitamins you are using
* Any existing health problems you have

Before starting, stopping, or changing the dose of any medication, including this one, you must consult with your doctor to confirm that it is safe to do so. This will help prevent any potential interactions or adverse effects.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

Before taking this medication, inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using it. If you have diabetes (high blood sugar), discuss this with your doctor, as this medication may increase your blood sugar levels.

It may take up to 2 weeks to experience the full effects of this medication. If your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently, contact your doctor immediately.

Dosage and Administration

Do not exceed the prescribed dose or use this medication more often than directed. Overdose can be fatal. Consult your doctor if you have any concerns.

Special Considerations

When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Monitor for signs such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these symptoms.

If you have a severe injury, undergo surgery, or develop an infection, you may require additional doses of oral steroids to help your body cope with these stresses. Carry a warning card indicating that you may need extra steroids in certain situations.

Long-term Use

Prolonged use of this medication may increase your risk of developing cataracts or glaucoma. Consult your doctor and schedule regular eye exams as recommended.

Long-term use may also lead to osteoporosis (weak bones). Discuss your risk factors with your doctor and ask about any concerns you may have. Additionally, you may be more susceptible to infections; therefore, practice good hygiene by washing your hands frequently and avoiding people with infections, colds, or flu.

Infections and Vaccinations

If you have not had chickenpox or measles before, avoid exposure to anyone with these conditions, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, contact your doctor immediately.

Special Populations

If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary; consult your doctor for more information.

Pregnancy and Breastfeeding

If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor.

COPD

If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk; consult your doctor to discuss the potential risks and benefits.
🆘

Overdose Information

Overdose Symptoms:

  • Formoterol overdose: Tachycardia, palpitations, tremor, headache, nausea, dizziness, hypokalemia, hyperglycemia, metabolic acidosis.
  • Budesonide overdose: Acute overdose is unlikely due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (e.g., Cushingoid features, adrenal suppression).

What to Do:

Seek immediate medical attention or call Poison Control (1-800-222-1222). Treatment is supportive and symptomatic. Monitor cardiac status (ECG), serum potassium, and glucose. Consider activated charcoal if recent ingestion. For chronic budesonide overdose, gradual withdrawal of corticosteroids may be necessary.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Acute bronchospasm (not for rescue therapy)
  • Status asthmaticus
🔴

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, atazanavir, clarithromycin, indinavir, nelfinavir, saquinavir, telithromycin): May significantly increase budesonide systemic exposure, leading to increased risk of Cushing's syndrome and adrenal suppression.
  • Other long-acting beta2-agonists (LABAs): Increased risk of cardiovascular adverse effects.
  • Beta-blockers (non-cardioselective): May block the bronchodilatory effect of formoterol and cause severe bronchospasm, especially in patients with asthma.
  • QT-prolonging drugs (e.g., quinidine, disopyramide, procainamide, phenothiazines, tricyclic antidepressants): Increased risk of ventricular arrhythmias due to additive QT prolongation.
🟡

Moderate Interactions

  • Diuretics (loop or thiazide): May potentiate hypokalemia and/or ECG changes associated with beta-agonists.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of formoterol (e.g., hypertension, tachycardia).
  • Sympathomimetics: Additive effects on cardiovascular system.
  • Xanthine derivatives (e.g., theophylline): May potentiate hypokalemia.
đŸŸĸ

Minor Interactions

  • Not specifically identified as minor interactions with significant clinical impact for this combination.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Asthma/COPD symptom control

Rationale: To assess baseline disease burden and guide initial therapy.

Timing: Prior to initiation of therapy.

Cardiac assessment (ECG, history)

Rationale: To identify pre-existing cardiac conditions that may be exacerbated by LABAs.

Timing: Prior to initiation, especially in patients with cardiovascular risk factors.

📊

Routine Monitoring

Pulmonary Function Tests (e.g., FEV1)

Frequency: Periodically (e.g., every 3-12 months or as clinically indicated)

Target: Improvement from baseline, stabilization of lung function.

Action Threshold: Worsening FEV1 or lack of improvement may indicate inadequate control or need for dose adjustment/alternative therapy.

Asthma/COPD symptom control (e.g., frequency of exacerbations, rescue inhaler use, nocturnal symptoms)

Frequency: At each follow-up visit (e.g., every 1-3 months initially, then every 3-12 months)

Target: Minimal symptoms, infrequent rescue inhaler use, no nocturnal symptoms.

Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal awakenings, or exacerbations indicate uncontrolled disease.

Growth monitoring (in pediatric patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age.

Action Threshold: Growth deceleration may indicate systemic corticosteroid effects.

Signs/symptoms of systemic corticosteroid effects (e.g., adrenal suppression, osteoporosis, cataracts, glaucoma, bruising)

Frequency: Periodically, especially with higher doses or prolonged use.

Target: Absence of signs/symptoms.

Action Threshold: Presence of signs/symptoms may require dose reduction or alternative therapy.

Serum potassium and glucose

Frequency: Periodically, especially in patients at risk for hypokalemia or hyperglycemia (e.g., concomitant diuretics, diabetes).

Target: Normal range.

Action Threshold: Significant deviations may require intervention or dose adjustment.

đŸ‘ī¸

Symptom Monitoring

  • Worsening asthma/COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for rescue inhaler
  • Chest pain or palpitations
  • Tremor or nervousness
  • Oral candidiasis (thrush) - inspect mouth and throat
  • Hoarseness or dysphonia
  • Blurred vision or eye pain (potential for glaucoma/cataracts)
  • Signs of infection (e.g., fever, increased sputum production)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Uncontrolled asthma poses a greater risk to both mother and fetus than the medication itself. Budesonide is generally considered safer than other inhaled corticosteroids in pregnancy.

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for budesonide. Formoterol is Category C.
Second Trimester: Generally considered safe if clinically indicated.
Third Trimester: Generally considered safe if clinically indicated. Monitor for signs of beta-agonist effects in the neonate (e.g., tachycardia, hypoglycemia) if exposure occurs close to delivery.
🤱

Lactation

Budesonide is excreted in breast milk but at low levels, and systemic exposure in the infant is expected to be minimal. Formoterol is also excreted in breast milk. The benefits of breastfeeding should be weighed against the potential risks. Generally considered compatible with breastfeeding due to low systemic absorption.

Infant Risk: Low risk of adverse effects in breastfed infants due to low systemic exposure.
đŸ‘ļ

Pediatric Use

Closely monitor growth velocity in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth. Use the lowest effective dose. Adrenal suppression is a potential risk, especially with higher doses or prolonged use. Not recommended for children under 6 years of age.

👴

Geriatric Use

No specific dose adjustment is required. However, elderly patients may be more susceptible to the cardiovascular effects of LABAs (e.g., tremor, palpitations) and systemic corticosteroid effects (e.g., osteoporosis, cataracts, glaucoma). Monitor for comorbidities and potential drug interactions.

Clinical Information

💎

Clinical Pearls

  • Budesonide/Formoterol is a maintenance medication and should not be used for acute relief of bronchospasm. Patients should always have a short-acting beta-agonist (SABA) rescue inhaler available.
  • Proper inhaler technique is crucial for efficacy. Educate patients on how to use the inhaler correctly and confirm their technique.
  • Rinsing the mouth and gargling with water after each dose helps prevent oral candidiasis (thrush) and dysphonia.
  • Patients should be advised not to stop therapy abruptly, especially if on high doses, due to the risk of adrenal insufficiency.
  • Regular follow-up is important to assess asthma/COPD control, monitor for adverse effects, and ensure adherence.
🔄

Alternative Therapies

  • Inhaled Corticosteroids (ICS) monotherapy (e.g., budesonide, fluticasone, mometasone)
  • Long-Acting Beta2-Agonists (LABA) monotherapy (e.g., formoterol, salmeterol, arformoterol) - generally not recommended for asthma without an ICS.
  • Long-Acting Muscarinic Antagonists (LAMA) (e.g., tiotropium, umeclidinium) - primarily for COPD, sometimes add-on for severe asthma.
  • Oral corticosteroids (for severe exacerbations or refractory disease)
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Immunomodulators (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma.
💰

Cost & Coverage

Average Cost: $250 - $400 per 120-inhalation canister (80/4.5 mcg)
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Preferred or Non-Preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to facilitate prompt and effective treatment.